U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ________________________________________________________________________________ 1. Name and Address of Reporting Person* Steven A. Cohen - -------------------------------------------------------------------------------- (Last) (First) (Middle) 72 Cummings Point Road - -------------------------------------------------------------------------------- (Street) Stamford CT 06902 - -------------------------------------------------------------------------------- (City) (State) (Zip) ________________________________________________________________________________ 2. Issuer Name and Ticker or Trading Symbol Sonus Pharmaceuticals, Inc. ("SNUS") ________________________________________________________________________________ 3. IRS Identification Number of Reporting Person, if an entity (Voluntary) ________________________________________________________________________________ 4. Statement for Month/Day/Year 11/27/2002 ________________________________________________________________________________ 5. If Amendment, Date of Original (Month/Day/Year) ________________________________________________________________________________ 6. Relationship of Reporting Person to Issuer (Check all applicable) [ ] Director [X] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) ------------------------ ________________________________________________________________________________ 7. Individual or Joint/Group Filing (Check applicable line) [X] Form filed by one Reporting Person [ ] Form filed by more than one Reporting Person ________________________________________________________________________________ ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================
5. Amount of 6. 4. Securities Owner- 2. 2A. 3. Securities Acquired (A) or Beneficially ship Trans- Deemed Trans- Disposed of (D) Owned Form: 7. action Execution action (Instr. 3, 4 and 5) Following Direct Nature of Date Date, if any Code ----------------------------- Reported (D) or Indirect 1. (Month/ (Month/ (Instr. 8) (A) Transaction(s) Indirect Beneficial Title of Security Day/ Day/ ---------- Amount or Price (Instr. 3 (I) Ownership (Instr. 3) Year) Year) Code V (D) and 4) (Instr.4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par 11/26/02 P 200 A $2.10 1,582,452 I (1) value $0.001 per share - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
5. 7. Number of Title and Amount Derivative 6. of Underlying 4. Securities Date Securities 2. 3A. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) Conver- Deemed action or Disposed Expiration Date ---------------- 1. sion or 3. Execution Code of(D) (Month/Day/Year) Amount Title of Exercise Trans- Date, (Instr. (Instr. 3, ---------------- or Derivative Price of action Date if any 8) 4 and 5) Date Expira- Number Security Derivative (Month/ (Month/ ------ ------------ Exer- tion of (Instr. 3) Security Day/Year) Day/Year) Code V (A) (D) cisable Date Title Shares - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ==================================================================================================================================== [TABLE CONTINUED BELOW]
[CONTINUATION OF TABLE FROM ABOVE]
9. Number of 10. Derivative Ownership Securities Form of 11. 8. Beneficially Derivative Nature Price of Owned Follow- Security of Indirect Derivative ing Reported Direct (D) or Beneficial Security Transaction(s) Indirect (I) Ownership (Instr. 5) (Instr. 4) (Instr. 4) (Instr. 4) - --------------------------------------------------------- - --------------------------------------------------------- - --------------------------------------------------------- ========================================================= Explanation of Responses: (1) The securities to which this report relates are held by S.A.C. Capital Associates, LLC ("Associates") and S.A.C. Healthco Fund, LLC ("Healthco"), limited liability companies of which S.A.C. Capital Advisors, LLC ("Advisors") and S.A.C. Capital Management, LLC ("Management") are investment managers. Pursuant to investment agreements, each of Advisors and Management share all investment and voting power with respect to the securities held by Associates and Healthco. The Reporting Person controls both Advisors and Management. In accordance with Instruction 4(b)(iv) the entire amount of the Issuer's securities held by Associates and Healthco is reported herein. The transaction reported on herein was consummated by Associates. The Reporting Person disclaims any beneficial ownership of any of the Issuer's securities to which this report relates for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
/s/ Peter Nussbaum November 27, 2002 - --------------------------------------------- ----------------------- **Signature of Reporting Person Date Peter Nussbaum Authorized Person Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the Form is filed by more than one Reporting Person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure.